This study provides evidence that OB GLP-1 signalling engages a top-down neural mechanism to control insulin secretion via the SNS
HUBERMAN: And that's why it's involved in helping us achieve our full height, our full stature
This makes it uniquely effective for: Visceral fat reduction (glucagon is specifically active on abdominal fat stores) Resting metabolic rate increase (glucagon is thermogenic it raises your metabolic baseline) Food noise suppression (GLP-1 component dampens reward-driven eating) Satiety signaling (GIP + GLP-1 extend fullness after meals) Because of this third mechanism, the clinical trial results for Retatrutide are notably better than other approved GLP-1s for body weight reduction
Tirzepatide, a newer medication, combines GLP-1 and GIP receptor agonists, which have a more potent effect on weight loss, with research showing it may lead to greater reductions in body weight compared to Semaglutide
If additional ophthalmic therapy is indicated, wait 5 to 10 minutes in between
doi: 10.1016/S0006-2952(03)00504-5 20